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Abstract
Background: Calcium is a vital mineral and an indispensable component of milk for ruminants. The regulation of
transcellular calcium transport by 1,25-dihydroxyvitamin D3 (1,25-(OH)2D3, the active form of vitamin D) has been
confirmed in humans and rodents, and regulators, including vitamin D receptor (VDR), calcium binding protein D9k
(calbindin-D9k), plasma membrane Ca
2+-ATPase 1b (PMCA1b), PMAC2b and Orai1, are involved in this process.
However, it is still unclear whether 1,25-(OH)2D3 could stimulate calcium transport in the ruminant mammary gland.
The present trials were conducted to study the effect of 1,25-(OH)2D3 supplementation and energy availability on
the expression of genes and proteins related to calcium secretion in goat mammary epithelial cells.
Methods: An in vitro culture method for goat secreting mammary epithelial cells was successfully established. The
cells were treated with different doses of 1,25-(OH)2D3 (0, 0.1, 1.0, 10.0 and 100.0 nmol/L) for calcium transport
research, followed by a 3-bromopyruvate (3-BrPA, an inhibitor of glucose metabolism) treatment to determine its
dependence on glucose availability. Cell proliferation ratios, glucose consumption and enzyme activities were
measured with commercial kits, and real-time quantitative polymerase chain reaction (RT-qPCR), and western blots
were used to determine the expression of genes and proteins associated with mammary calcium transport in dairy
goats, respectively.
Results: 1,25-(OH)2D3 promoted cell proliferation and the expression of genes involved in calcium transport in a
dose-dependent manner when the concentration did not exceed 10.0 nmol/L. In addition, 100.0 nmol/L 1,25-(OH)
2D3 inhibited cell proliferation and the expression of associated genes compared with the 10.0 nmol/L treatment.
The inhibition of hexokinase 2 (HK2), a rate-limiting enzyme in glucose metabolism, decreased the expression of
PMCA1b and PMCA2b at the mRNA and protein levels as well as the transcription of Orai1, indicating that glucose
availability was required for goat mammary calcium transport. The optimal concentration of 1,25-(OH)2D3 that
facilitated calcium transport in this study was 10.0 nmol/L.
Conclusions: Supplementation with 1,25-(OH)2D3 influenced cell proliferation and regulated the expression of
calcium transport modulators in a dose- and energy-dependent manner, thereby highlighting the role of 1,25-(OH)2D3
as an efficacious regulatory agent that produces calcium-enriched milk in ruminants when a suitable energy status was
guaranteed.
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Background
As a crucial macro-mineral for animals, calcium has func-
tions in many physiological processes, including skeletal
formation, nerve pulse transmission, muscle contraction,
blood clotting, stimulus secretion coupling, and is an in-
dispensable component of milk [1–3]. Milk is a naturally
calcium-rich fluid produced by animals and humans. Ac-
tually, the total calcium concentration in ruminant milk is
approximately 30 mmol/L [4]. It was reported that a sub-
stantial calcium flux was generated from blood to milk
during the lactation period [5–8]. Accordingly, there must
be a precise regulatory mechanism involved in the modu-
lation of calcium transport in the mammary glands of
dairy animals.
It is not entirely understood how mammary epithelial
cells (MECs) extract large quantities of ionized calcium
from plasma and produce a calcium-rich secretion,
particularly for ruminants. The blood total calcium
levels of dairy cows have a narrow range (approxi-
mately 2.0 to 2.5 mmol/L) [8]; thus, the process of cal-
cium transport in the mammary gland occurs against a
tremendous concentration gradient. Moreover, Van-
Houten and Wysolmerski [9] reported the existence of
transcellular calcium transport and summarized this
process in human MECs. Consequently, it can be ex-
trapolated that the transcellular process is involved in
calcium transport during milk secretion in ruminants.
Calcium-transport proteins, such as calcium bind-
ing protein-D9k (calbindin-D9k), plasma membrane
Ca2+-ATPase 1b (PMCA1b) and 2b (PMCA2b), have
been confirmed as essential elements for transcellular
calcium transport [5, 7, 10, 11]. According to recent
research, Orai1, a pore subunit of the Ca2+ release-
activated Ca2+ (CRAC) channels, is essential for cal-
cium entry into cells and calcium homeostasis [12–14],
but no trial has been conducted in mammary epithelial
cells from dairy goats. Evidence circumstantiated that
1,25-dihydroxyvitamin D3 (1,25-(OH)2D3), the active form
of vitamin D, was the most critical regulator of trans-
cellular calcium transport and body calcium homeosta-
sis [1, 15, 16]. 1,25-(OH)2D3 stimulated mammary
calcium transport to elevate the milk calcium content
by upregulating calbindin-D9k and PMCA2b in lactat-
ing mice; knockout mice were used in this study [17].
Furthermore, 1,25-(OH)2D3 has been reported to facili-
tate the synthesis of epithelial calcium channels, in-
crease the expression of plasma membrane calcium
pumps, and induce the formation of calbindin in
humans, rats and other species [18–20]. In addition,
Kohler et al. [21] measured the blood concentrations of
1,25-(OH)2D3 in lactating goats at different altitudes,
but the potential regulatory effects of 1,25-(OH)2D3 on
mammary calcium transport and milk secretion, such
as the expression of key regulators, were not studied. In
summary, few research studies called attention to goat
mammary calcium transport, and it has not been fully
elucidated whether 1,25-(OH)2D3 regulates calcium
transport in goat MECs.
Therefore, we hypothesized that 1,25-(OH)2D3 supple-
mentation could modulate the expression of genes in-
volved in calcium transport in goat MECs in a dose-
dependent manner. Meanwhile, as an active transport




In the present research, all the procedures and operation
were approved by the Animal Welfare Committee of
Institute of Animal Nutrition and Feed Science, College
of Animal Science and Technology, Northwest A&F
University, Yangling, Shaanxi, P.R. China.
In vitro culture of goat mammary epithelial cells
Dulbecco’s Modified Eagle Medium F12 (DMEM/F-12),
fetal bovine serum (FBS), epidermal growth factor (EGF)
and 0.25 % trypsin were purchased from Life Technolo-
gies (Carlsbad, California, USA). Penicillin, streptomycin,
insulin and hydrocortisone were obtained from Sigma-
Aldrich (Shanghai, China). The other materials used for
cell culture were provided by Dr. Xiaofei Wang from
the Institute of Animal Nutrition and Feed Science,
Northwest A&F University, China.
Three healthy China Guanzhong dairy goats that had
been raised in the livestock farm of Northwest A&F Uni-
versity since birth were selected for this study and used
during the second parity and at peak lactation (day in
milk (DIM) = 60 d). In detail, a 1 cm3 sample of the par-
enchymal tissue of the mammary gland was collected
and placed in sterilized tubes containing ice-cold D-
Hanks’ balanced salt solution (D-HBSS; pH = 7.4) after
official approval for scientific sampling, and the tubes
were immediately and aseptically transported to the la-
boratory immediately and aseptically. The tissue samples
were washed with D-HBSS several times until the
washing buffer was transparent, then sheared into 0.5
to 1.0 mm3 cubic fragments with a sterilized surgical
scissor, and washed until clean. These fragments were
placed in empty 60 mm cell culture dishes (Corning,
New York, USA), maintaining an approximate distance
of 0.5 cm between pieces, and the dishes were incubated
in a cell incubator (Thermo Scientific, Massachusetts,
USA) at 37 °C in 5 % CO2 and 95 % air for 30 min.
Then, 1 mL of basal medium was added and incubated
for 2 h, followed by the addition of another 1 mL of
basal medium and incubation for an additional 48 h.
The basal media contained 90 % DMEM/F-12 and 10 %
FBS, and the concentrations of penicillin, streptomycin,
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insulin, hydrocortisone and EGF were 100.0 U/mL,
100.0 μg/mL, 5.0 μg/L, 1.0 μg/L and 1.0 μg/L, respect-
ively. The medium was substituted for fresh basal medium
every 48 h. When 90-95 % of the dish was occupied by
visible cells under an inverted microscope (Nikon, Tokyo,
Japan), the cells could be passaged. The cells were digested
with 0.25 % trypsin for 5 min and passaged to new dishes.
Subsequently, the medium was transferred to separate
new culture plates 40 min later and incubated for 48 h to
remove the fibroblasts. The adhesion time for fibroblasts
(30 to 40 min) was shorter than that of MECs; hence,
purified MECs were procured after the last procedure was
repeated 5 times. The MECs were previously character-
ized by Wang et al. [22] in our college.
Experimental design
Purified MECs passaged to 7–12 generations were used
in this study. The cells were seeded in 24-well flat-
bottom culture plates (Corning, New York, USA) at a
density of 2.0 × 104 cells per well. Afterward, 700 μL of
basal medium was added to each well and incubated for
24 h. The medium was removed, the cells were washed
with sterilized phosphate-buffered saline (PBS; pH = 7.4)
3 times, and then 700 μL/well of treatment medium con-
taining 1,25-(OH)2D3 (Sigma-Aldrich, Shanghai, China)
was added. The final concentrations of 1,25-(OH)2D3 in
the medium were 0, 0.1, 1.0, 10.0 and 100.0 nmol/L, re-
spectively. Each treatment was conducted on 6 replicates
with 1 replicate per passage to avoid the potential effects
of different passages. Culture dishes were incubated under
the same conditions described above for 24 h, and then
the subsequent steps and analyses were implemented.
A specific inhibitor of hexokinase 2 (HK2), 3-
bromopyruvate (3-BrPA; Sigma-Aldrich, Shanghai, China),
was added to the medium to investigate the potential ef-
fects of the cellular energy status on calcium transport.
HK2 phosphorylates glucose to generate glucose-6-
phosphate (G6P), the first step in the cellular glucose ca-
tabolism, and HK2 inhibition is usually used to study the
effect of energy status on metabolic processes [23]. The
concentrations of 1,25-(OH)2D3 were 0 or 10.0 nmol/L,
and the 3-BrPA concentrations were 0 or 50.0 μmol/L, re-




tetrazolium bromide (MTT) Kit was obtained from
Jiancheng Bioengineering Institute (Nanjing, China) to
measure cell proliferation. Briefly, the MECs were
seeded in a 96-well plate (2.0 × 104 cells/well; Corning,
New York, USA) and were incubated with basal medium
(200 μL/well) at 37 °C in 5 % CO2 and 95 % air for 24 h.
Subsequently, the basal medium was replaced with
treatment medium (150 μL/well) and incubated under
standard conditions for 24 h. Then, 1× MTT (50 μL/well)
was added and incubated under the same conditions for
4 h. The supernatant was removed carefully and 150 μL
dimethyl sulfoxide (DMSO; Amresco, OH 44139, USA)
was added to each well, followed by an 8 min mixing
process using a Tablet Shaker (Kylin-Bell Lab Instruments
Co., Ltd., Jiangsu, China). The absorbance at 570 nm was
determined using a Microplate Reader (Power Wave XS2,
Bio Tek, USA).
Glucose determination
The glucose content in the medium was determined via
a Glucose Assay Reagent Kit (Jiancheng, Nanjing, China)
based on the glucose oxidase/peroxidase colorimetric
method. Medium samples were collected in each well of
culture dishes. The reaction reagent (1,000 μL) and li-
quid sample (10 μL) were mixed in a pure plastic tube,
incubated at 37 °C for 15 min, and then the optical
density (OD) at 505 nm was read on a Microplate
Reader (Power Wave XS2, Bio Tek, USA). The OD of a
tube with a standard glucose (Sigma-Aldrich, Shanghai,
China) solution was determined using the same method
as the test wells. The glucose concentration is presented
in millimoles per liter (mmol/L).
Total protein assay of MECs
The total protein content of the treated MECs was de-
termined using a Coomassie Protein Assay Reagent
(Jiancheng, Nanjing, China). The cells were lysed using a
repeated freeze-thaw fragmentation method. Accord-
ingly, the MECs were frozen at −80 °C for 60 min and
transferred to a 37 °C water bath for 15 min to thaw the
cells, which was repeated 3 times. Samples of the cell
debris and contents were collected by adding 300 μL of
a 0.9 % sodium chloride (NaCl) solution to each well.
Double distilled water (blank control), a standard protein
solution and sample liquid with an equal volume (50 μL)
were mixed with 3.0 mL of reagent and incubated at
room temperature for 10 min. Finally, the OD was re-
corded at a specific wavelength (595 nm) and optical
path (1 cm) using a U3900 Spectrophotometer (Hitachi,
Tokyo, Japan).
Real Time Quantitative Polymerase Chain Reaction (RT-qPCR)
Total RNA was extracted from the MECs using an
RNAprep Pure Cell/Bacteria Kit (TIANGEN, Beijing,
China). The purity and concentration of the total RNA
was determined using a NanoDrop 2000 UV–vis Spec-
trophotometer (Thermo Scientific, Massachusetts, USA).
Reverse transcription was performed with a PrimeScript®
RT reagent Kit (Takara Biotechnology, Dalian, China),
and the cDNA samples were stored at −20 °C until further
analysis. The mRNA expression levels of the facilitative
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Na+-independent glucose transporters (GLUT1 and
GLUT12), vitamin D receptor (VDR), calbindin-D9k,
PMCA1b, PMCA2b and Orai1 were measured using a
SYBR® Premix Ex Taq™ II (Takara Biotechnology, Dalian,
China). Briefly, a 20 μL reaction system was used that con-
sisted of 10 μL of SYBR Premix Ex Taq II (2×), 0.8 μL of
forward primer (10.0 μmol/L), 0.8 μL of reverse primer
(10.0 μmol/L), 1 μL (500 ng) of cDNA, and 7.4 μL of
RNase-free water. The reaction procedure was performed
using an iCycler iQ5 multicolor real-time PCR detection
system (Bio-Rad Laboratories, Hercules, CA) with the fol-
lowing program: 95 °C for 5 min; 35 cycles of 95 °C for
10 s, 60 °C for 30 s, and 72 °C for 30 s; and 72 °C for
5 min. All samples were run in triplicate, and the 2-△△Ct
method, which was previously established by Livak [24],
was adopted to analyze the gene expression data. The
primers are presented in Table 1, and β-actin was used as
a reference gene in this study.
Western blot
After treatments, the supernatant fluid was removed and
the cells were washed three times. Total protein was ex-
tracted using a High Performance RIPA buffer (Solarbio
Science & Technology Co., Ltd., Beijing, China) in which
the final concentration of phenylmethylsulfonyl fluor-
ide (PMSF; Roche, Shanghai, China) was 1.0 mmol/L.
The cells were collected in a 4 °C-precooled Eppendorf
tube using a cell scraper, and the cells were lysed for
30 min at 4 °C. Afterward, the turbid liquid was centri-
fuged at a speed of 13,000 r/min for 10 min at 4 °C.
The supernatant contained the total protein and was
collected for further analysis. The western blot analysis
was conducted according to the protocols reported by
Xu et al. [29]. Briefly, the protein content was deter-
mined using a Pierce™ bicinchoninic acid (BCA) Pro-
tein Assay Kit (Thermo Scientific, Rockford, USA),
according to the manufacturer’s instructions. The total
proteins were separated by SDS-PAGE, transferred to
nitrocellulose membranes (Millipore, Billerica, USA),
and then probed with the primary antibodies anti-
PMCA1b, anti-PMCA2b and anti-β-actin, which were
all purchased from Abcam (Cambridge, UK). Goat
anti-rabbit IgG (Abcam, Cambridge, UK) was used as a
secondary antibody. The chemiluminescent ECL west-
ern blot assay system (Thermo, Rockford, USA) was
used to detect the signals.
Enzyme activity assay
A Hexokinase Test Kit (Jiancheng, Nanjing, China) was
used to detect the HK activity of the solutions contain-
ing cell debris, and the samples were collected according
to the user’s manual. The prepared reagent was pre-
warmed at 37 °C for 10 min, and then 50 μL of liquid
sample and 960 μL of reagent were immediately mixed
in a tube to start the reaction. The absorbance at
340 nm (optical path: 0.5 cm) was recorded after 30 s
(OD1) using a U3900 Spectrophotometer (Hitachi,
Tokyo, Japan). Subsequently, the liquid was transferred
back to the previous tube and warmed in a 37 °C water
bath for 2 min. The absorbance was measured again
under the same conditions and denoted as OD2. The
HK activity was calculated using the following formula:
Table 1 Primer sequences used for the RT-qPCR analysis
Genes Strand Sequences (5′-3′) Source
β-actin Forward CCTGCGGCATTCACGAAACTAC JX046106.1
Reverse ACAGCACCGTGTTGGCGTAGAG
Calbindin-D9k Forward TCTCCAGAAGAACTGAAGGGC XM_005701057.2
Reverse CCAACACCTGGAATTCTTCG
GLUT1 Forward GCTAGCATGGAGCCCACCAGCAAG JQ343217.1
Reverse AAGCTTTCACACTTGGGAATCAGCTCC
GLUT12 Forward GGAAAAGTGACCGCTCGTG JQ798185.1
Reverse TGTCCTGGTAGGCAAAGAACTG
VDR Forward GCACTTCCTTACCTGACCCC [25]
Reverse CCGCTTGAGGATCATCTCCC
PMCA1b Forward GAGACCATGGCTTGCTGAGT [26]
Reverse GACCTTCTGGTACTGCCACC
PMCA2b Forward GCATTTTCATCGGGTTAGGAG [27]
Reverse AGAGCTACGAAACGCCTTCAC
Orai1 Forward CAGCGTGCATAATATACCTAACTCTACCCG [28]
Reverse GTATTGATGAGGAGAGCAAGCGTGAAT











 C proteinð Þ
where “6.22” represents the millimolar extinction coeffi-
cient, “2” represents the reaction time (min), “0.5” repre-
sents the optical path (cm), and “1.01/0.05” refers to the
dilution factor.
The Na+K+-ATPase and Ca2+Mg2+-ATPase activities
were detected with a Trace ATPase Test Kit (Jiancheng,
Nanjing, China). Protein samples were mixed with the
appropriate reagents (different reagents for these two
enzymes) and heated in a 37 °C water bath for 10 min;
then, another reagent was added to the reaction system
and centrifuged at 3,500 r/min for 15 min. The superna-
tants were collected to determine the inorganic phosphate
(Pi) concentration. The Pi samples were treated with the
appropriate reagents at room temperature for 2 min.
Afterward, a final reagent was added and incubated at
room temperature for 5 min. The OD values at 636 nm
(optical path: 1 cm), including blank control (ODblank),
control (ODcontrol), standard product (ODstandard) and
sample (ODsample), were read using a Microplate Reader
(Power Wave XS2, Bio Tek, USA). The formula to deter-




 0:02 6 7:8
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where “0.02” represents the concentration of the stand-
ard Pi solution (μmol/mL), “6” represents the reaction
time (min), and “7.8” represents the dilution factor.
Statistical analysis
The data were subjected to one-way analysis of variance
(ANOVA) using Statistical Product and Service Solu-
tions 21.0 (SPSS 21.0; IBM SPSS Statistics, USA), and
multiple comparisons were performed using Duncan’s
method [30]. The values were presented as the means ±
SE (standard error). The results were declared signifi-
cantly different if P < 0.05.
Results
Cell proliferation
Supplementation with 1,25-(OH)2D3 significantly pro-
moted MEC proliferation as the concentration increased
from 0.1 to 10.0 nmol/L (P < 0.05, Fig. 1a), and no differ-
ence was observed between the control and the 0.1 nmol/L
group (P > 0.05). Compared with the control, the rates of
cell proliferation at the concentration of 0.1, 1.0, 10.0 and
100.0 nmol/L were increased by 3.79 %, 9.16 %, 15.99 %
and 8.09 %, respectively. The cell proliferation rate in the
100.0 nmol/L group (P < 0.05) was lower than the
10.0 nmol/L group. In addition, the proliferation rate in the
100.0 nmol/L group was statistically equal to the 1.0 nmol/
L group (P > 0.05).
Cell proliferation was inhibited in the 3-BrPA-
supplemented group and the 3-BrPA plus 1,25-(OH)2D3
group (P < 0.05, Fig. 1b), and proliferation decreased by
37.85 % and 31.64 %, respectively. Increased cell prolif-
eration was observed in the 1,25-(OH)2D3 group with-
out 3-BrPA supplementation (P < 0.05). Whether or not
the 1,25-(OH)2D3 was supplemented, no difference was
observed in the MECs treated with 3-BrPA (P > 0.05).
Glucose consumption
The 0.1 nmol/L 1,25-(OH)2D3 treatment did not affect
the glucose consumption by the goat MECs (P > 0.05,
Fig. 2). The glucose uptake was significantly promoted
when the 1,25-(OH)2D3 concentration increased from
0.1 to 10.0 nmol/L (P < 0.05). In accordance with cell
Fig. 1 Proliferation of goat mammary epithelial cells in response to
different 1,25-(OH)2D3 concentrations (a) and supplementation (b)
with 1,25-(OH)2D3 (10.0 nmol/L) and 3-bromopyruvate (50.0 μmol/L)
D = 1,25-Dihydroxyvitamin D3 (1,25-(OH)2D3, 10.0 nmol/L), B = 3-
bromopyruvate (3-BrPA, 50.0 μmol/L), B + D = 3-BrPA plus 1,25-
(OH)2D3. Different letters within a single figure represent a significant
difference (P < 0.05)
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proliferation, 100.0 nmol/L 1,25-(OH)2D3 decreased glu-
cose consumption compared with the 10.0 nmol/L treat-
ment (P < 0.05), and no differences were observed
between 1.0 and 100.0 nmol/L (P > 0.05).
Gene expression
The expression of genes related to calcium transport in
goat MECs were presented in Fig. 3. An increase in VDR
expression was observed as the 1,25-(OH)2D3 levels in-
creased from 0 to 10.0 nmol/L (P < 0.05), whereas no effect
was observed between 10.0 and 100.0 nmol/L (P > 0.05).
The same trend was observed for calbindin-D9k, with the
exception of an insignificant difference at 0.1 nmol/L com-
pared with the control. In addition, supplementation with
10.0 and 100.0 nmol/L 1,25-(OH)2D3 increased PMCA1b
expression (P < 0.05), and the peak PMCA1b expression
level appeared at 10.0 nmol/L (P < 0.05). However, 1,25-
(OH)2D3 had no influence on PMCA1b expression at con-
centrations of 0 and 1.0 nmol/L (P > 0.05).
The 1,25-(OH)2D3 supplementation altered the GLUT1
and GLUT12 gene expression levels as well (Fig. 4). There
was an increase in GLUT1 mRNA abundance as the 1,25-
(OH)2D3 levels increased from 0.1 to 10.0 nmol/L (P <
0.05, Fig. 4a). No difference was observed between the
control and 0.1 nmol/L. However, compared with
10.0 nmol/L 1,25-(OH)2D3, the 100 nmol/L treatment did
not increase GLUT1 expression (P > 0.05). Inconsistently,
supplementation with 1,25-(OH)2D3 had no influence on
GLUT12 expression when the concentration was less than
1.0 nmol/L (P > 0.05, Fig. 4b). The 10.0 nmol/L treatment
promoted GLUT12 expression compared to the 1.0 nmol/
L treatment (P < 0.05), and there was no difference be-
tween the 10.0 and 100.0 nmol/L treatments (P > 0.05).
Supplementation with 3-BrPA down-regulated PMCA1b
and PMCA2b expression (P < 0.05, Fig. 5a and b),
regardless of whether 1,25-(OH)2D3 was added. The ex-
pression levels of PMCA1b and PMCA2b in group D
(10.0 nmol/L 1,25-(OH)2D3) were higher than those of the
Fig. 2 Glucose uptake of goat mammary epithelial cells in response
to different 1,25-(OH)2D3 concentrations. Values with different letters
were declared significant (P < 0.05)
Fig. 3 Expression of the vitamin D receptor (VDR), calcium binding
protein D9k (Calbindin-D9k) and plasma membrane Ca
2+-ATPase 1b
(PMCA1b) genes in goat mammary epithelial cells in response to
different 1,25-(OH)2D3 concentrations. Different letters within a single
figure represent a significant difference (P < 0.05)
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control. Specifically, the 1,25-(OH)2D3 treatment up-
regulated PMCA1b expression in the 3-BrPA-
supplemented groups (P < 0.05, Fig. 5a), but no dif-
ference in PMCA2b expression was observed (P >
0.05, Fig. 5b). As we could see from the immuno-
blots (Fig. 5c), the changes in the levels of the
PMCA1b and PMCA2b proteins in the supplemented
groups were similar to the changes in the transcripts.
As shown in Fig. 6, the expression levels of GLUT1
and Orai1 were increased by 1,25-(OH)2D3 supplemen-
tation (P < 0.05) and reduced by the addition of 3-BrPA
(P < 0.05). No difference was observed between the 3-
BrPA-supplemented group and 1,25-(OH)2D3 plus 3-
BrPA group (P > 0.05).
Cell metabolic enzymes
As a whole, the enzyme activities, including HK, Ca2+Mg2
+-ATPase and Na+K+-ATPase, were increased when the
1,25-(OH)2D3 levels increased from 0 to 10.0 nmol/L
(Table 2). Compared with the 10.0 nmol/L treatment, de-
creased activities were detected in the 100.0 nmol/L group
(P < 0.05). The HK activity in the 100.0 nmol/L group was
statistically equal to the 0.1 nmol/L and control groups
(P > 0.05). Supplementation with 0.1 nmol/L 1,25-(OH)2D3
did not affect the Ca2+Mg2+-ATPase and Na+K+-ATPase
activities (P > 0.05), and no difference in Ca2+Mg2+-ATPase
activity was observed between the 0.1 and 1.0 nmol/L
groups (P > 0.05). The Na+K+-ATPase activity in the
100.0 nmol/L group was equivalent to the control (P >
0.05). Moreover, the Ca2+Mg2+-ATPase activity presented a
sudden decrease at the highest 1,25-(OH)2D3 concentra-
tion, which was even lower than the control (P < 0.05).
Fig. 4 Expression of the facilitative Na+-independent glucose
transporter (GLUT1 and GLUT12) genes in goat mammary epithelial
cells in response to different 1, 25-(OH)2D3 levels. Different letters
within a single figure represent a significant difference (P < 0.05)
Fig. 5 Expression of the plasma membrane Ca2+-ATPase 1b
(PMCA1b, A) and 2b (PMCA2b, B) genes and representative
immunoblots (C) of PMCA1b, PMCA2b and β-actin in goat mammary
epithelial cells in response to supplementation with 1,25-(OH)2D3
(10.0 nmol/L) and 3-bromopyruvate (3-BrPA, 50.0 μmol/L). D = 1,25-
Dihydroxyvitamin D3 (1,25-(OH)2D3, 10.0 nmol/L), B = 3-bromopyruvate
(3-BrPA, 50.0 μmol/L), B + D = 3-BrPA plus 1,25-(OH)2D3. Different letters
within a single figure represent a significant difference (P < 0.05)
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Discussion
1,25-Dihydroxyvitamin D3 is a natural ligand of the
vitamin D receptor (VDR), and plays an important role
in anti-inflammatory processes and calcium transport
[31, 32]. It has been reported that 1,25-(OH)2D3 could
activate the VDR to modulate gene transcription and
mineral ion homeostasis [33, 34]. Vitamin D-facilitated
calcium transport is a complicated process, including
the up-regulation and down-regulation of associated
genes. Calbindin-D9k, PMCAs and Orai were considered
essential elements for transcellular calcium transport
following stimulation with 1,25-(OH)2D3 [10, 11, 35, 36].
Our data showed that 1,25-(OH)2D3 influenced the ex-
pression of the VDR, calbindin-D9k, PMCA1b, PMCA2b
and Orai1 genes in goat MECs in a dose-dependent man-
ner, which indicated enhanced calcium transport. Further-
more, we could infer that this process was closely related
to cellular energy availability, based on the changes in
GLUT1 and GLUT12 expression and the responses after
the inhibition of HK2.
Supplementation with 1,25-(OH)2D3 improved cell
proliferation in a concentration-dependent manner, with
the exception of a relative decrease at 100.0 nmol/L.
Our results were inconsistent with the results reported
by Rayalam et al. [37], who found that 1,25-(OH)2D3 en-
hanced preadipocyte viability generated from 3 T3-L1
mouse embryo fibroblasts in a dose-dependent manner
from 0.1 to 10.0 nmol/L, but no significant difference
existed between the 10.0 and 100.0 nmol/L treatments.
However, the proliferation of human airway smooth
muscle cells (HASMCs) was gradually inhibited by in-
creasing levels of 1,25-(OH)2D3 in another experiment
[38]. These variant effects might result from different
cell types and functions as well as from the tolerated
doses. Due to the high calcium content of milk, MECs
assimilate large amounts of calcium from plasma. In
addition, calcium is an essential element for cell growth,
differentiation and maintenance. Consequently, it is
plausible that the 1,25-(OH)2D3-induced promotion of
calcium uptake can enhance MECs proliferation. To our
knowledge, this was the first study in which 1,25-
(OH)2D3-stimulated cell proliferation of secreting MECs
was investigated.
Mammary lactation is a complicated biological process
that is sustained by a variety of nutrients, among which
glucose acts as the supreme precursor for lactose syn-
thesis as well as an energy resource of metabolic activ-
ities [23]. Hence, glucose plays an essential role in
mammary milk secretion. It has been testified that glu-
cose transporters (GLUTs) are the main tools for glucose
uptake by mammary epithelial cells, and GLUT1 was the
major transporter, although GLUT12 is involved as well
[23, 39]. Previous studies rarely called attention to the
effects of 1,25-(OH)2D3 on glucose uptake and metabol-
ism. In our present study, 1,25-(OH)2D3 increased cell
glucose consumption and up-regulated GLUT1 and
Fig. 6 Expressions of the facilitative Na+-independent glucose
transporter1 (GLUT1, a) and Orai1 genes (b) in goat mammary
epithelial cells in response to supplementation with 1,25-(OH)2D3
(10.0 nmol/L) and 3-bromopyruvate (3-BrPA, 50.0 μmol/L). D = 1,25-
Dihydroxyvitamin D3 (1,25-(OH)2D3, 10.0 nmol/L). Different letters
within a single figure represent a significant difference (P < 0.05)
Table 2 Effect of the 1,25-(OH)2D3 concentration on the metabolic enzyme activities in goat mammary epithelial cells
Item 1,25-(OH)2D3 concentration, nmol/L
0 0.1 1.0 10.0 100.0
Hexokinase, U/gprot 74.92 ± 1.25a 78.02 ± 1.92a 83.37 ± 1.73b 89.52 ± 2.14c 77.72 ± 1.59a
Ca2+Mg2+-ATPase, U/mgprot 0.71 ± 0.03b 0.78 ± 0.04bc 0.85 ± 0.07c 0.96 ± 0.11d 0.62 ± 0.09a
Na+K+-ATPase, U/mgprot 1.47 ± 0.07a 1.54 ± 0.12ab 1.63 ± 0.09b 1.81 ± 0.12c 1.46 ± 0.11a
a-dSuperscripts with varied letters in the same row were significantly different (P < 0.05). Values are presented as the Means ± SE (standard error)
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GLUT12 expression, indicating that more glucose was
utilized for cell metabolism or component synthesis. In
addition, intracellular glucose phosphorylation catalyzed
by HK is the first step in energy metabolism and is a
rate-limiting process. Consequently, the increased HK
activity was another persuasive indicator of glucose
utilization [23, 40]. The main reason for the enhanced
glucose consumption might be that 1,25-(OH)2D3-in-
duced calcium transport led to the promotion of milk
secretion in goat MECs. In addition, several studies have
shown that 1,25-(OH)2D3 regulated the immune re-
sponse in ruminants [41–43], which also required energy
to sustain the process.
1,25-(OH)2D3 is a flexible secosteroid and exerts its
regulatory functions by binding to VDR, a specific nu-
clear receptor and DNA-binding transcription factor [44].
A series of biological processes, such as maintaining cal-
cium homeostasis and mediating inflammation responses,
are triggered by the binding between ligand and receptor
[45]. We found that 0 to 10.0 nmol/L 1,25-(OH)2D3 pro-
moted VDR expression, with no difference between the
10.0 and 100.0 nmol/L treatments. This finding indicated
that 1,25-(OH)2D3 could increase the number of VDRs in
a dose-dependent manner, with an optimal concentration
of 10.0 nmol/L. Haussler et al. [44] noted that the activa-
tion and function of VDR were induced by 1,25-(OH)2D3,
but saturation was not mentioned. From the authors’
point of view, the cell metabolic capacity was limited and
could not be induced in an unlimited manner. This hy-
pothesis was supported by the results from a previous
study by Rayalam et al. [37], who discovered that 1,25-
(OH)2D3 could no longer promote adipocyte growth when
the concentration exceeded 10.0 nmol/L.
The diffusion of intracellular calcium from the apical
side to basolateral side depends on its binding to
calbindin-D9k, and calcium passes through the basolat-
eral side via PMCA1b [1, 5, 9, 10]. An overall increase in
the calbindin-D9k and PMCA1b transcripts was detected
when the 1,25-(OH)2D3 concentrations ranged from 0 to
10.0 nmol/L, which was a marker to distinguish the en-
hanced calcium transport. According to previous find-
ings, both calbindin-D9k and PMCA1b had a vitamin D
response element (VDRE) in their promoter region, and
the VDRE was the direct binding site of VDR [37, 46, 47],
which may be why 1,25-(OH)2D3 could regulate transcel-
lular calcium transport. Moreover, there are other proteins
that regulate cellular calcium transport. Using a null mu-
tation mouse model, Reinhardt et al. [48] showed that the
activity of PMCA2b, another isoform of PMCA, was re-
quired for the secretion of milk calcium, and Ji et al. [17]
showed that 1,25-(OH)2D3 could stimulate PMCA2b ex-
pression to regulate mammary calcium transport. Davis
et al. [28] suggested that Orai1, a novel channel, was im-
portant for mammary calcium transport during lactation.
Orai1 is a key component of the CRAC channels and
plays an extremely important role in the transmembrane
influx of calcium [13, 14, 36]. The biology and molecu-
lar mechanism of Orai1 have been reviewed by Cahalan
et al. [12] and Hogan et al. [49]. The 1,25-(OH)2D3-
stimulated up-regulation of PMCA2b and Orai1, to-
gether with their down-regulation by the inhibition of
glucose metabolism, indicated that calcium transport in
goat MECs could be regulated by 1,25-(OH)2D3 avail-
ability and the cellular energy status.
Plasma membrane Ca2+-ATPase is a transcellular Ca2+
transporter encoded by the PMCA gene family that plays
a vital role in regulating cellular calcium metabolism and
maintaining intracellular Ca2+ homeostasis [28, 50].
Ca2+Mg2+-ATPase activity showed a similar trend as
the expression of PMCA1b and PMCA2b, indirectly
indicating that calcium secretion was promoted when the
1,25-(OH)2D3 concentration did not exceed 10.0 nmol/L.
Additionally, there was recent evidence showing
that Na+/Ca2+ exchangers (NCX) on the mammalian
plasma membrane co-modulated calcium transport
with PMCA [50, 51]. Moreover, Zanatta et al. [52] found
that 1,25-(OH)2D3 mediated transcellular calcium trans-
port by stimulating NCX activation in rat Sertoli cells.
Our data also showed an increase in Na+K+-ATPase
activity as the 1,25-(OH)2D3 levels increased from 0 to
10.0 nmol/L. However, NCX expression was not examined
in this study; therefore, we could not verify its regulatory
role in the Ca2+ transcellular transport process.
Previous studies showed that 3-BrPA inhibited glycoly-
sis in a dose-dependent manner by decreasing HK activ-
ity, particularly HK2; thus it has been widely used to
investigate the impact of cellular energy status on bio-
logical processes [53, 54]. In our trials, the effect of en-
ergy availability on calcium transport in goat MECs was
studied by supplementing the cells with 3-BrPA. Accord-
ingly, cell proliferation and GLUT1 expression de-
creased, which was most likely due to the inhibition of
glucose metabolism. In support of our findings, Yun
et al. [53] described that glycolysis inhibitors, such as 3-
BrPA, could inhibit cell and tumor growth at proper
dosages. The decrease in PMCA1b and PMCA2b ex-
pression at the mRNA and protein levels, as well as
down-regulated Orai1 transcription, attested that cal-
cium transport was inhibited in goat MECs. Hence,
1,25-(OH)2D3 promoted calcium transport in goat
MECs, and this process depended on the intracellular
availability of glucose. It is well known that glucose is
the main energy source of many metabolic activities, and
active nutrient transport is a process that expends en-
ergy. Therefore, the inhibition of glycolysis reduced
PMCA and Orai1 expression.
Compared with the 3-BrPA group, the 3-BrPA plus
1,25-(OH)2D3 group exhibited higher PMCA1b
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expression, whereas GLUT1 expression showed no dif-
ference, indicating that 1,25-(OH)2D3 could still enhance
calcium transport when glucose uptake was suppressed
in goat MECs. To our knowledge, this was a novel dis-
covery. Many substances, such as clenbuterol [55] and
conjugated linoleic acids (CLAs) [56], have been proven
to induce nutrient repartition. We speculated that the
stimulation of 1,25-(OH)2D3 repartitioned cellular en-
ergy for calcium secretion, but this assumption required
convincing support. More trials are required to explore
the roles of PMCAs, Orai1, NCX and other potential
proteins. From the authors’ point of view, mammary cal-
cium secretion is a complicated system, and multiple,
cross-linked networks should be established via tran-
scriptomics and proteomics technologies to better under-
stand milk calcium synthesis. In addition, the isotope
tracer technology should be used to directly reflect mam-
mary calcium transport in dairy goats.
Conclusions
Suitable concentrations of 1,25-(OH)2D3 promoted prolif-
eration and glucose utilization in goat MECs in a dose-
dependent manner. Supplementation with 1,25-(OH)2D3
could modulate calcium transport by altering the expres-
sion of VDR, calbindin-D9k, PMCA1b, PMCA2b and
Orai1 in a dose- and energy-dependent manner. In the
present study, the optimal concentration of 1,25-(OH)2D3
that stimulated the expression of calcium transport indica-
tors in goat MECs was 10.0 nmol/L. Our findings
highlighted the role of 1,25-(OH)2D3 as a potential regula-
tory agent to produce calcium-enriched milk in ruminants
when sufficient intracellular energy was available.
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